Skip to main content

The Specialists

On paper, USPTO trademark applications route to examiners with no specialized units. In the record, twenty examiners received 40% of the cannabis-named filings on 2.0% of the docket — and one examiner has cited the same TEQUILA registration against 325 applications.

August 6, 20269 min read1.7M applications · 565 office actions read
The same 20 examiners: 2.0% of everything, 40.0% of cannabis-named marksTwo horizontal bars on a 0 to 50 percent axis. Share of all filings examined: 2.0 percent. Share of cannabis-named filings examined: 40.0 percent.0%10%20%30%40%50%Share of all filings examined2.0%Share of cannabis-named filings examined40.0%
The 20 sweep examiners' share of active-fleet applications filed 2014 or later (33,996 of 1,699,228), against their share of the cannabis-named subset (930 of 2,327; mark-name term match). Source: CrystalMark, public USPTO records.
The 20-examiner group's share of applications examined, overall versus cannabis-named, active fleet, filed 2014 or later.
PopulationGroup shareApplications
Share of all filings examined2.0%33,996 of 1,699,228 applications
Share of cannabis-named filings examined40.0%930 of 2,327 applications

In one sentence: the USPTO has no official specialist examiners, but the record shows several — a de facto cannabis desk fifteen examiners strong, a failure-to-function desk hiding inside the same statistic, and a handful of examiners whose §2(d) practice runs one registration deep.

§ 1 · The fingerprint

A refusal profile that shouldn't exist.

Across the active fleet, when an application draws a substantive refusal, §2(d) likelihood of confusion is among its grounds 64%of the time, and a ground outside the familiar named list — the “other substantive” bucket — 14% of the time. Then there is Robert J. Struck of Law Office L90: §2(d) at 29%, other substantive at 51%, across a 19,109-application docket. No classifier error produces a swing that large on a sample that big.

Reading his office actions explains it. In a 39-document sample spread across 2014–2026, roughly three quarters of his “other” refusals are lawful-use refusals: the mark cannot be registered because the goods cannot lawfully move in commerce under the Controlled Substances Act, with the FDCA appearing alongside for ingestible CBD after the 2018 Farm Bill and drug-paraphernalia grounds close behind. The docket reads the same way — DR. GRINSPOON, LIBERTY HAZE, CHARLOTTE'S WEB HEMP, PERFECT SPLIFF, NYC BUD. His grounds mix was fleet-normal through 2013; at the 2017 peak, 77% of his refusal-bearing applications drew an “other” ground. The timeline is the cannabis policy timeline.

One examiner with a concentrated docket is an anecdote. So we ran the same scan across the whole active fleet.

§ 2 · The desk

Twenty examiners, 40% of the cannabis-named docket.

The scan: every active examiner whose “other substantive” share exceeds 30% on 500or more applications. The fleet mode is 10–20%; the gate is roughly double that, and exactly 20examiners cross it. We then pulled about thirty “other”-bucket office actions for each — 565 documents read in all — and tallied the statutory grounds actually asserted. For fifteen of the twenty, the top ground is the same one Struck writes: lawful use under the CSA. Jeffrey J. Look is the purest case, at 26 of 30 documents.

The concentration receipt is the chart at the top of this piece. Since 2014, these twenty examiners handled 2.0% of the applications examined by the active fleet — and 40.0% of the applications whose mark names contain an unambiguous cannabis term (930 of 2,327). That is twenty times their fair share, on an undercounted subset: a mark name is the least subtle way to sell cannabis, and the proxy only sees names.

The USPTO does not publish assignment mechanics, and nothing in the public record says why these applications land where they land. Deliberate routing and self-reinforcing workload clustering look identical from the outside; what the record shows is the concentration itself. There is an obvious logic to it either way: lawful-use refusals turn on a moving body of law — state legalization, the Farm Bill, delta-8, the FDCA — and a desk that writes them every week has the current law in hand.

§ 3 · The same statistic, a different desk

Two of the twenty see almost no cannabis marks.

Five of the twenty gate-crossers broke the pattern, and two of them had essentially zero cannabis-named filings. Their documents tell a different story. Tara J. Pate refuses on failure to function as a mark in 20 of 30 documents read, with §2(a) refusals in 15 — the informational-matter desk. Judith Michelle Helfman runs failure-to-function in 19 of 30 with ornamental refusals in 8 — the desk where slogans on t-shirts go to be told they are not trademarks. The remaining three run mixed dockets between the two families.

The lesson generalizes. An outlier statistic flags a docket; it cannot name it. The naming took reading the documents.

The cannabis / lawful-use desk · CSA is the top ground read

The failure-to-function desk

  • Law Office S10 · n=3,418
    failure-to-function in 20 of 30 · §2(a) in 15
  • Law Office M70 · n=12,298
    failure-to-function in 19 of 30 · ornamental in 8

Mixed dockets · both families present

§ 4 · The corridors

One examiner, one registration, 325 applications.

Ground mix is one axis of specialization. The other lives inside §2(d) itself: examiners who cite the same blocking registration over and over, for years. To measure it, take every active examiner with at least 300 applications carrying an extracted §2(d) citation — 384 examiners — and ask what share of those applications their single most-cited registration appears in. The median answer is 0.8%. The 90th percentile is 1.7%. Repeat citation is rare — which is what makes the exceptions remarkable.

Exactly two examiners clear 10%. Ronald G. McMorrow of Law Office M90 has cited the certification mark TEQUILA (Reg. 5225126) against 325 distinct applications — 22.6% of his entire cited docket, twenty-eight times the fleet median. If you file an agave-spirit mark, there is, in effect, a tequila examiner, and the citation is predictable before you file. Christina Sobral of L90 is the wine-country counterpart: NAPA GREEN (Reg. 3704740) against 114 applications, NAPA VALLEY against 48, 100% NAPA VALLEY against 47.

Below the 300-application floor, two more corridors are forming. John Joseph Schmidt of N10 has cited a registration for the standalone mark AI (Reg. 7629644) against 66 of his 241 cited applications — 27.4%, higher than any examiner above the floor, riding the AI naming boom. Lisa Anne Papale of N30 has cited each of two related 1-800-DOCTORS registrations against 49 of her 209.

A corridor fight is its own genre. The tequila and Napa blockers are certification marks, so the dispute is less about consumer confusion between two brands and more about whether your mark trespasses on a protected designation — a different brief, with its own case law. None of it is visible in a refusal-rate statistic. McMorrow's §2(d) numbers look like a normal tough examiner; the corridor only appears when you count the registrations he cites.

§ 5 · What this means for your prosecution

Know the desk before you brief the refusal.

  1. A cannabis-adjacent mark changes the fight before you file.

    If the goods touch cannabis, hemp, or CBD, the refusal to brief for is lawful use in commerce under Sections 1 and 45 — with the FDCA riding along for ingestible CBD — and the §2(d) landscape matters less than it would anywhere else. The draw is measurably tilted toward examiners who write these refusals every week and know the case law cold.

  2. Check the corridor before you clear.

    For an agave spirit, a Napa wine, or an AI-formative name, the blocking registration is already on the record dozens to hundreds of times. Clearance for these marks should start from the assumption that the citation is coming and answer it in the application as filed.

  3. The statistic can't name the desk.

    Two examiners with the same outlier ground profile turned out to run two entirely different desks — one refuses cannabis marks, the other refuses slogans. The number flags the docket; only the documents say what it is. That read is what an examiner profile is for.

Methodology

All figures re-derived against production data on August 6, 2026. Active fleet = examiners with at least one office action in the trailing 365 days. Docket-share receipt: applications filed 2014-01-01 or later with a named mark and a known active-fleet examiner (1,699,228; the 20-examiner group examined 33,996 = 2.0%). Cannabis-named = mark name matching a fixed term list (CBD, HEMP, CANNAB-, KUSH, THC, 420, MARIJUANA, WEED, DELTA-8/9, DISPENSAR-, DAB, BUD, SATIVA, INDICA, GANJA, TERPEN-): 2,327 applications, 930 to the group (40.0%). A wider list adding vape/smoke terms gives 27.8% (1,018 of 3,659); the conclusion is unchanged. Name proxies undercount — subtle marks say nothing. Sweep: the 20 candidates are every active examiner with other-substantive share > 30% on n ≥ 500; 565 of 568 sampled “other”-bucket office actions were readable via USPTO TSDR, and grounds were tallied from statutory language with hand checks. Struck's 39-document sample was drawn separately (3 per year, 2014–2026). Roster application counts are full dockets, all years — not the 2014+ subset. Corridor definition: distinct applications where the examiner's §2(d) refusals cite a given registration ÷ distinct applications with any extracted citation, floor 300 (384 examiners; median top-share 0.8%, p90 1.7%; citation extraction validated at 99.93% agreement on a 1,350-document corpus). Grounds shares quoted for the fleet (64% §2(d), 14% other) are per-application among substantive-refusal applications, as published on examiner profiles. Everything here is built from public USPTO records; examiner links go to profiles built from the same records.

The per-examiner version

Your examiner's desk is knowable before you respond.

Every profile carries the grounds mix, the most-cited registrations, and what has overcome each — the same reads this piece is built on, for all ~950 active examiners.

Look up your examiner

The next drop, in your inbox

Get the next research drop in your inbox. No spam — one email per release.